Stable inhibition of SH3TC2 significantly limited the growth of the tumor, resulting in decreased tumor size (Figure 7B), tumor weight (Figure 7C), and tumor volume (Figure 7D). This evidence concerns the gene SH3TC2 and neoplasm.